3,4-Dihydroxybenzylamine hydrobromide
This small molecule, 3,4-Dihydroxybenzylamine hydrobromide, acts as a DNA polymerase inhibitor, demonstrating anti-proliferative effects across multiple melanoma cell lines irrespective of their tyrosinase activity levels. It is a research tool for investigating melanoma biology and evaluating potential chemotherapeutic mechanisms in vitro.
Product Specifications
CAS Number
16290-26-9
Product Name Alternative
RNA Synthesis, RNASynthesis, tyrosinase, Tumor, 3,4 Dihydroxybenzylamine hydrobromide, 3,4-Dihydroxybenzylamine, 3,4Dihydroxybenzylamine hydrobromide, 3,4-Dihydroxybenzylamine Hydrobromide, DNA/RNA Synthesis, DNA Synthesis, DNA polymerase, DNASynthesis, NSC263475, NSC-263475, NSC263475 Hydrobromide, NSC-263475 Hydrobromide, NSC 263475 Hydrobromide, NSC 263475, NSC 263475 hydrobromide, inhibit, Inhibitor, melanoma
Field of Research
Cell Biology, Molecular Biology
Purity
97.28% (May vary between batches)
Solubility
DMSO:80 mg/mL (363.54 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (15 mM)
Smiles
Br.NCc1ccc (O) c (O) c1
Molecular Formula
C7H10BrNO2
Molecular Weight
220.06
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6245149-01 0.1 mL
VEGF (Vascular Endothelial Growth Factor, Vascular Permeability Factor, VEGFA, VPF) (MaxLight 405)
Sign In for Pricing
View Details MBS6245149-02 5x 0.1 mL
VEGF (Vascular Endothelial Growth Factor, Vascular Permeability Factor, VEGFA, VPF) (MaxLight 405)
Sign In for Pricing
View Details